« Back to Record
Citation APA

Ingle, J. N., Tu, D., Pater, J. L., Martino, S., Robert, N. N., Muss, H. B., Piccart-Gebhart, M., Castiglione, M., Shepherd, L., Pritchard, K., Livingston, R., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., & Goss, P. E. (2006). Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast cancer research and treatment, 99(3), 295-300. doi:10.1007/s10549-006-9207-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55399

Ingle, J. N., Tu, D., Pater, J. L., Martino, S., Robert, N. N., Muss, H. B., Piccart-Gebhart, M., Castiglione, M., Shepherd, L., Pritchard, K., Livingston, R., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., & Goss, P. E. (2006). Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast cancer research and treatment, 99(3), 295-300. doi:10.1007/s10549-006-9207-y